Financials

  • Market Capitalization 2.11 B
  • Employee 325
  • Founded 2006
  • CEO Pravin Dugel
  • Website www.ocutx.com
  • Headquarter Delaware, United States
  • FIGI BBG001J1BZV0
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-5.88
Rapporto prezzo/fatturato
30.69

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
1931
MESO
Mesoblast Limited - American Depositary Shares
18.19 USD+8.66%+29.93%+31.53%+61.83%2.33 B USD
1932
SNDX
Syndax Pharmaceuticals, Inc. - Common Stock
23.83 USD-1.24%-0.17%+28.74%+158.74%2.11 B USD
1958
ATAI
AtaiBeckley Inc. - Common Stock
5.68 USD+0.18%+5.58%+47.92%+43.80%2.09 B USD
1968
ABCL
AbCellera Biologics Inc. - Common Shares
6.75 USD+0.15%-11.53%+29.06%+70.03%2.06 B USD

Notizie